Email UpdatesSubstance Use in Women Research Report
This research report from NIDA discusses sex and gender influences in substance use, highlighting the unique needs of women when addressing substance use. disorder treatment
Public domain
Tools are available for public use without current copyright or licensing restrictions, primarily published by Federal, State, or local governments.
2019 National Survey On Drug Use And Health: Women
These reports and detailed tables present estimates from the 2019 National Survey on Drug Use and Health (NSDUH), specifically pertaining to substance use among women.
Drugs and Lactation Database (LactMed)
The LactMed® database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the levels of such substances in breast milk and infant blood, and the possible adverse effects in the nursing infant.
Index to Drug-Specific Information
This FDA page provides an index of over 400 FDA approved drugs and their descriptions. Note that it does not include all FDA approved drugs, but shares other resources to find more information on drugs not included on the list.
The Case for Screening and Treatment of Co-Occurring Disorders
SAMHSA offers evidence-based resources to help providers screen, diagnose, and deliver integrated care to patients with co-occurring disorders.
Reducing Polysubstance Use in Pregnancy
In this webinar, Drs. John Iskander and Suzanne Gilboa discuss what CDC and its partners are doing to reduce prenatal substance exposure and how screening and brief interventions may reduce prenatal substance exposure and improve the health of women and infants.
Checklist of Evidence-Based Recommendations for Caring for Pregnant Women with Opioid Use Disorder
The following checklist intends to support health care teams in providing evidence-based recommendations for treating pregnant and postpartum patients with OUD. The checklist is divided into five sections, sequenced by timing of presentation to care.
TAPS
The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool consists of a combined screening component (TAPS-1) followed by a brief assessment (TAPS-2) for those who screen positive.
Proposed Guidance for Toxicology Testing of Pregnant Patients
This guidance provides recommendations for screening pregnant patients for substance use disorder (SUD) to enhance the well-being of the maternalfetal dyad.
Words Matter: Improving the Substance Use Conversation A Guide for Health Care Teams
This Guide to meant to help health care teams recognize, rethink and remediate the stigma and bias of words commonly used in caring for people with the chronic disease of substance use disorder: